← Evidence map

ArticleJournal of neuro-oncology2023

Dose-dependent efficacy of bevacizumab in recurrent glioblastoma.

Jawad M Melhem et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36749445